Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I think every long here knows why Nuvilex changed their business model...this is old news and the company has been very open about the turnaround of the company...they were losing money in the other business model and scratched it for the new direction by acquiring the rights to Cell-in-a-Box not only for all cancers but then went back and acquired the rights for Diabetes too..
bull
ada....until confirmed it means nothing..it could go either way and the fact that we are above yesterdays close bodes well for the stock
tarballmonger....yep that is from the 27th so the pivot is .46...we are going to battle there...but if they bring it over that today...up we go....
I think everyone should start saying goodbye to the .30's......
chart showed support at last gap right around .39
bull
Nuvilex Funding Has Investors Preparing for Milestone Announcements in Late-Phase Clinical Trials
Nuvilex Funding Has Investors Preparing for Milestone Announcements in Late-Phase Clinical Trials
NEW YORK, NY--(Marketwired - Mar 3, 2014) - Nuvilex (OTCQB: NVLX) investors who have patiently waited for the R&D biotech to reach a point where late-phase clinical trials were a reality, are probably relishing these truly exciting times after a Chicago-based institutional investor committed to fund $27 million dollars toward the company's clinical trials in advanced inoperable pancreatic cancer. Leading up to the aforementioned clinical trials, investors can expect to see a list of milestone developments unfold, and for those who consider themselves biotech junkies, they know this is when the fun begins.
It is likely just a matter of time now before investors start hearing words like Good Manufacturing Practices (GMP), Principal Investigator (PI), Protocol, Contract Research Organization (CRO), Study Sites, etc., and with each of these milestone developments, Nuvilex draws closer to the actual patient recruitment process and eventual patient enrollment for the clinical trials.
Additional news events to pay attention to will be the cloning of the cancer-drug-activating cells that are required for the clinical trials. The cloning began last November at Inno Biologics, and this process is necessary to obtain the large numbers of cells required for the late-phase trials. Also, locating facilities in which the encapsulation of these large numbers of cells can be done according to GMP standards is also crucial, and the company says GMP compliance is an absolute requirement for drug regulatory authorities. With funding now flowing into the company, expect to see activity start to pick up.
For those unfamiliar with where Nuvilex is heading, here's a quick recap. Nuvilex acquired the exclusive worldwide rights to use the Cell-in-a-Box(TM) live-cell encapsulation technology to develop treatments for diabetes and any form of cancer. Now the company is preparing to advance late-phase clinical trials using the licensed pancreatic cancer treatment that combines Cell-in-a-Box with the anti-cancer drug ifosfamide to build upon two previous independent Phase II clinical trials.
The excitement for the company and its investors is that, in those two completed Phase II trials, the treatment that Nuvilex owns the rights to use outperformed Eli Lilly's long-time single-agent treatment for advanced inoperable pancreatic cancer, Gemzar(R) (gemcitabine), and Celgene's recently approved drug Abraxane (a nanoparticle formulation of the widely used drug Taxol with albumin) in combination with gemcitabine.
If Nuvilex's late-phase clinical trials can continue to outperform Celgene's therapy, then the company's treatment will likely be the new "gold standard" for the disease -- a designation that earned Eli Lilly's drug Gemzar more than $10 billion when it was the "gold standard" for advanced inoperable pancreatic cancer. It is numbers like this that make it clear why so many have remained patient with their Nuvilex investment, and we haven't even begun to discuss the company's future in diabetes!
http://online.wsj.com/article/PR-CO-20140303-906831.html
ok I know I am a research the internet nerd here but related to my post on Wall Street Journal MarketWatch....I also watch what comes up first when I Google...the seeking alpo trash blog was the first thing up since Friday when you google Nuvilex....all of a sudden it is not and I don't know what page back it got shoved to...
Nuvilex Home of Biotechnology
www.nuvilex.com/?
The live-cell encapsulation technology employed by Nuvilex is a way to enclose living cells in protective “cocoons” about the size of the head of a pin - we do not ...
?Pancreatic Cancer - ?News - ?Live-Cell Encapsulation - ?Management
News for nuvilex
Nuvilex Comprehensive Analyst Report Answers Vital Questions for Shareholders, by BrokerBank Securities, Inc.
Wall Street Journal ?- 4 days ago
NEW YORK, Feb. 26, 2014 /PRNewswire/ -- Nuvilex, Inc. (OTCQB: NVLX) owns exclusive rights to a cancer treatment platform that has ...
Chicago Investment Firm Assumes $27 Million Risk to Help Nuvilex unseat Celgene and Eli Lilly
MarketWatch? - 6 days ago
Facebook CEO says WhatsAPP Worth More than $19B; Lincoln Park Capital Invests in Nuvilex
MarketWatch? - 5 days ago
that tells you a lot because it tells you exactly what everyone is reading because more clicks on the site brings it up....
bull
CHECK THIS OUT...I did not catch this and no one has mentioned it..
the headline for Wall Street Journal MarketWatch...
3 days before the hit piece came out by seeking alpo....
Feb. 25, 2014, 4:48 a.m. EST....
Facebook CEO says WhatsAPP Worth More than $19B; Lincoln Park Capital Invests in Nuvilex
http://www.marketwatch.com/story/facebook-ceo-says-whatsapp-worth-more-than-19b-lincoln-park-capital-invests-in-nuvilex-2014-02-25
need I say more....
I will for the new investors...
putting Nuvilex in a headline with Facebook in a deal they had just made to buy WhatsApp Inc. for $19 billion
3 days later we get hit...no coincidence.....
oh we are so going up
bull
very interesting.....
Migelito...your comment is why the ones like us who do our best with DUE DILIGENCE tries to tell people... do your DD...we know we are not going to get through to the day traders or swing traders ...they are all trading off of trash emails...they don't care...they make there profit and move on...and it is ok if you find the stock somewhere in that midst of chaos...but then do you DD and don't just jump on a stock until you do....
one thing that has always served me well when I do my DD is I don't look for the articles that they shove in front of my face...I try to find a reason...any reason out there on the internet why I SHOULD NOT own the stock.....not reading trash bash....and when I can't find that on my own...I buy...with confidence and I hold....and it works...GL
bull
tarballmonger.....yes...the best place to read up is Nuvilex...under their news ....
http://www.fiercebiotech.com/press-releases/nuvilex-describes-critical-advantages-live-cell-encapsulation-technology
http://austrianova.com/
guys ...here is your first rebuttal..even before monday...longs do your part to support the fact that Goldman rebutted that pos SA and re-post his article...he is doing this for all the good guys...I have posted it several times...help me out....
http://www.goldmanresearch.com/20140302725/The-Goldman-Guide/shorts-are-nothing-but-deceivers.html
Today’s edition of The Goldman Guide is the most important piece we have written in four years for anyone that is long small cap stocks.
Not only do I encourage you to read this piece in its entirety but I highly recommend you forward this to anyone you know that invests in small stocks. Tweet about it. Post it on message boards. The word needs to get out:
Short sellers are nothing but deceivers and you can make money at their expense. Do not fear them.
March 2, 2014
Volume 5, Issue 9
The Goldman Guide
SHORTS ARE NOTHING BUT DECEPTIVE
iconDownload This Report in PDF
I have been around this business for 25 years and I have reached my breaking point. Long ago I pledged not to attack others in this business, but no more. Not only do I encourage you to read this piece in its entirety but I highly recommend you forward this to anyone you know that invests in small stocks. Tweet about it. Post it on message boards. The word needs to get out:
Short sellers are nothing but deceivers and you can make money at their expense.
The conventional wisdom has always been that short sellers are the smartest investors in the equity market. They relish in the fiction that gives them superhuman powers to pick apart a balance sheet, income statement, a company’s business model and operations, intellectual property, etc.
The sad truth is that short sellers are wolves in sheep’s clothing. They portray themselves as the unofficial “investor branch” of the Consumer Protection Agency when they are the ruthless deceivers who know no bounds when it comes to their short attacks.
This is the shorts’ playbook: Lies? No problem. Falsehoods? Keep ‘em coming. Deflect attention away form the truth by focusing on the irrelevant? Work it, baby. Claim all proponents are greedy shills? Do it all day long.
One of the great ironies of the shorts’ theses is that they claim anyone that is paid to promote a stock has a financial incentive and therefore should not be believed. If that is the case, no one should believe a short, EVER! Especially since many of them are themselves paid shills.
Why? Because a short position by its nature could lose an infinite amount of money. Therefore, it is the short sellers that have the greatest financial incentive to say whatever they need to, in order to destroy a company’s market value, lest it rise. In the case of Nuvilex, Inc. (OTCQB—NVLX—Spec Buy), a stock that rose from $0.10 on 12/31/13 to $0.62 last week must have cost shorts a fortune.
For longtime followers of GSCR, you know that NVLX is one of our all-time winners. The shorts have tried in vain to crush it for years yet it has risen from $0.03 when we initiated coverage to the $0.62 high. Hence, the hatchet piece released Friday.
(Editor’s Note: We have covered NVLX for nearly 3 years and have been compensated from time to time by the Company and a third party to publish reports and articles. However, GSCR has not been compensated for this blog nor is management aware of its publication prior to release.)
It is no surprise that NVLX was hammered, as those with big profits in the past few weeks sought to take money off the table following the big rise, which was prompted by a “short story” on Seeking Alpha released as the stock was breaking out on huge volume. If one looks at the NVLX stock chart, it is obvious that the big rise in the stock from $0.20 to $0.62 was after the Company announced huge funding news which effectively de-risked the stock and enables it to initiate late-stage pancreatic cancer clinical trials. Moreover, it is a tremendous validation of the technology and model from a noted institutional investor. The SA article barely made mention of this critical and incredibly favorable news choosing instead to focus on promotion, third parties, medical marijuana initiatives, and irrelevant operations from years ago, etc. to deflect attention from the true reasons for the interest in the stock.
Look, the shorts typically win and have the day, but it is usually short-lived unless there is egregious fraud or mismanagement. For example, Bill Ackman of Pershing Square admitted that his short on Herbalife (NYSE—HLF) is his biggest all-time loser as the company has done nothing but post record results and hit new highs time and time again. Still, since he has a major financial incentive to keep it down, he engages in a relentless lobbying and public relations campaign to derail the stock.
So what does one do when a short assaults a stock? If one believes the short’s thesis does not have merit, the price reduction caused by the short’s efforts typically fizzle out after a time, leaving investors with the opportunity to invest in the stock at lower prices. As milestones are reached, and gaps are filled, the stock tends to make a big run-up higher that is not associated with short-covering. That capitulation phase comes later, at least in small parts, driving a stock to new highs.
Longs should also expect that when a short introduces his thesis on a stock, even some so-called investment pros pile on with negative comments and stories. Folks, this is the real tragedy. These schmucks are nothing but naïve paeans that are trying to make themselves look smart by piling on when in truth, especially with small stocks, they are clueless as to what really drives them and how to take advantage of them. They bash the company and the proponents (paid and non-paid) even when proven wrong over and over and side with the shorts that have the greatest and truest amount of money to lose. (I give you 2 guesses as to the poster child for this example.)
If you believe in a stock that is in the crosshairs of shorts and bashers and the stock and company perform, there is no greater satisfaction or profitability, and the profits from such events happen more often and faster than you think.
bull
p.s. I only have 9 posts remaining.....lol
here's the link to the Goldman rebuttal..
http://www.goldmanresearch.com/20140302725/The-Goldman-Guide/shorts-are-nothing-but-deceivers.html
Goldman Small Cap responds to seeking alpha hit .....
Shorts Are Nothing But Deceivers
Tweet
Today’s edition of The Goldman Guide is the most important piece we have written in four years for anyone that is long small cap stocks.
Not only do I encourage you to read this piece in its entirety but I highly recommend you forward this to anyone you know that invests in small stocks. Tweet about it. Post it on message boards. The word needs to get out:
Short sellers are nothing but deceivers and you can make money at their expense. Do not fear them.
SHORTS ARE NOTHING BUT DECEPTIVE
Tweet
Today’s edition of The Goldman Guide is the most important piece we have written in four years for anyone that is long small cap stocks.
Not only do I encourage you to read this piece in its entirety but I highly recommend you forward this to anyone you know that invests in small stocks. Tweet about it. Post it on message boards. The word needs to get out:
Short sellers are nothing but deceivers and you can make money at their expense. Do not fear them.
March 2, 2014
Volume 5, Issue 9
The Goldman Guide
SHORTS ARE NOTHING BUT DECEPTIVE
iconDownload This Report in PDF
I have been around this business for 25 years and I have reached my breaking point. Long ago I pledged not to attack others in this business, but no more. Not only do I encourage you to read this piece in its entirety but I highly recommend you forward this to anyone you know that invests in small stocks. Tweet about it. Post it on message boards. The word needs to get out:
Short sellers are nothing but deceivers and you can make money at their expense.
The conventional wisdom has always been that short sellers are the smartest investors in the equity market. They relish in the fiction that gives them superhuman powers to pick apart a balance sheet, income statement, a company’s business model and operations, intellectual property, etc.
The sad truth is that short sellers are wolves in sheep’s clothing. They portray themselves as the unofficial “investor branch” of the Consumer Protection Agency when they are the ruthless deceivers who know no bounds when it comes to their short attacks.
This is the shorts’ playbook: Lies? No problem. Falsehoods? Keep ‘em coming. Deflect attention away form the truth by focusing on the irrelevant? Work it, baby. Claim all proponents are greedy shills? Do it all day long.
One of the great ironies of the shorts’ theses is that they claim anyone that is paid to promote a stock has a financial incentive and therefore should not be believed. If that is the case, no one should believe a short, EVER! Especially since many of them are themselves paid shills.
Why? Because a short position by its nature could lose an infinite amount of money. Therefore, it is the short sellers that have the greatest financial incentive to say whatever they need to, in order to destroy a company’s market value, lest it rise. In the case of Nuvilex, Inc. (OTCQB—NVLX—Spec Buy), a stock that rose from $0.10 on 12/31/13 to $0.62 last week must have cost shorts a fortune.
For longtime followers of GSCR, you know that NVLX is one of our all-time winners. The shorts have tried in vain to crush it for years yet it has risen from $0.03 when we initiated coverage to the $0.62 high. Hence, the hatchet piece released Friday.
(Editor’s Note: We have covered NVLX for nearly 3 years and have been compensated from time to time by the Company and a third party to publish reports and articles. However, GSCR has not been compensated for this blog nor is management aware of its publication prior to release.)
It is no surprise that NVLX was hammered, as those with big profits in the past few weeks sought to take money off the table following the big rise, which was prompted by a “short story” on Seeking Alpha released as the stock was breaking out on huge volume. If one looks at the NVLX stock chart, it is obvious that the big rise in the stock from $0.20 to $0.62 was after the Company announced huge funding news which effectively de-risked the stock and enables it to initiate late-stage pancreatic cancer clinical trials. Moreover, it is a tremendous validation of the technology and model from a noted institutional investor. The SA article barely made mention of this critical and incredibly favorable news choosing instead to focus on promotion, third parties, medical marijuana initiatives, and irrelevant operations from years ago, etc. to deflect attention from the true reasons for the interest in the stock.
Look, the shorts typically win and have the day, but it is usually short-lived unless there is egregious fraud or mismanagement. For example, Bill Ackman of Pershing Square admitted that his short on Herbalife (NYSE—HLF) is his biggest all-time loser as the company has done nothing but post record results and hit new highs time and time again. Still, since he has a major financial incentive to keep it down, he engages in a relentless lobbying and public relations campaign to derail the stock.
So what does one do when a short assaults a stock? If one believes the short’s thesis does not have merit, the price reduction caused by the short’s efforts typically fizzle out after a time, leaving investors with the opportunity to invest in the stock at lower prices. As milestones are reached, and gaps are filled, the stock tends to make a big run-up higher that is not associated with short-covering. That capitulation phase comes later, at least in small parts, driving a stock to new highs.
Longs should also expect that when a short introduces his thesis on a stock, even some so-called investment pros pile on with negative comments and stories. Folks, this is the real tragedy. These schmucks are nothing but naïve paeans that are trying to make themselves look smart by piling on when in truth, especially with small stocks, they are clueless as to what really drives them and how to take advantage of them. They bash the company and the proponents (paid and non-paid) even when proven wrong over and over and side with the shorts that have the greatest and truest amount of money to lose. (I give you 2 guesses as to the poster child for this example.)
If you believe in a stock that is in the crosshairs of shorts and bashers and the stock and company perform, there is no greater satisfaction or profitability, and the profits from such events happen more often and faster than you think.
bull
Phase III Trials have not started yet...it would benefit you guys to do some DD since you have the internet at your fingertips...
bull
Nuvilex will get there one day...
take a look at INO..seeking alpo was trashing that stock last spring and summer @ .50....it went to 3.73 and is
@ 3.29 today....
celgene once had a price of .06 and sits at 160.00 today
jimmyjones ....Canadians have been on the mb's saying they are trading the stock just fine and the cease trade order was only BC..
and the company has no intentions of changing anything so why are you still on here.....go find another stock...quit bashing
British Columbia Securities Commission - Cease Trade Order
May 27, 2011
OTC Disclosure & News Service
Vancouver, BC, Canada -
2011 BCSECCOM 250
Cease Trade Order
Nuvilex, Inc.
On May 27, 2011, the Company received a Cease Trade Order from the British Columbia Securities Commission notifying the Company that trading of the Company’s securities would cease on the British Columbia Securities Exchange. The reason cited for the Cease Trade Order, a copy of which is attached hereto as an Exhibit, is that the Company failed to file copy of its press releases and quarterly financial reports with the British Columbia Securities Commissionas required under Part 7 of NI 51-502 and section 5(b) of BCI 51-509.
The Company was unaware of any filing requirements or obligations of the British Columbia Securities Commission; however, it subsequently learned that an analyst report was inadvertently emailed by a broker to several Canadian residents, creating a filing obligation under the regulations hereinabove cited.
Nuvilex has relatively few Canadian shareholders and there was minimal trading of the Company’s securities on the British Columbia Securities Exchange prior to the Cease Trade Order. Accordingly, Nuvilex does not anticipate that the Cease Trade Order will have a material effect on the Company’s operations or liquidity.
JoeDaddy..thanks ...I was looking for that today...
jimmyjones ...why don't you go take care of that for all the BC..residents since that is the only place it stopped trading ...and I know for fact that they already explained why to you over in the yahoo insane asylum...go back and read it again...
JoeDaddy..I bet you are right...
hey JoeDaddy...I know I posted this before but it really does put it into perspective how strong this stock is.....
Friday...due for a pullback....down .08 ....not a bad day....
last red day in a sea of green we opened @ .3929 and closed @ .3270...down .0659...
Friday
the stock opened down @ 0.4194 from day before close of 0.51 and in the first 15 minutes the stock dropped all the way to 0.4250 on 8.1 million shares...
that right there tells you that pos SA and others knew before open bell that they were going to short the stock.....because the pos blog didn't come out until 11:07 but on a good note...
after that drop investors and traders jumped at the op to buy shares and drove the stock up to 0.62..and yes they shorted it and sold it back down...but the strength that took this stock up to 0.62 in a matter of 1hr 24 m....was pretty good....
perspective guys
bull
27 MILLION DOLLAR FUNDING for Phase III Trials
Was the death sentence for the shorts..we knew it...the little slimy friggen freaking out short seller knew it...he was desperate...that's all folks...it doesn't matter because as soon as they announce the Phase III Trials that are funded the short game loses a s**tload of steam...it debunks what they have been mouthing off all these yrs...sure they will think up new crap...so what...where would we get our humor from during the week...I am not selling one tiny little share of this company...I am still in disbelief that I finally found my Hidden Gem...and granted I do not have as many shs as some of you who bought for pennies...I would of added more Friday...what a great buying op... but I am fully invested with my stocks...still I am way ahead with my 364,000 shs...and I plan on us retiring in my beach house with my seafood shack and my dog Emma...with ONLY occasional visits from my kids and my granddaughter anytime she wants...best to all longs...keep up the good work
bull
the stock opened down @ 0.4194 from day before close of 0.51 and in the first 15 minutes the stock dropped all the way to 0.4250 on 8.1 million shares...that right there tells you that pos SA and others knew before open bell that they were going to short the stock.....because the pos blog didn't come out until 11:07 but on a good note...after that drop investors and traders jumped at the op to buy shares and drove the stock up to 0.62..and yes they shorted it and sold it back down...but the strength that took this stock up to 0.62 in a matter of 1hr 24 m....was pretty good....
bull
Technical....I gave you guys this on the last red candle..that is why I said it would go up the next day...
the last one closed above the previous days open...important...today's close .4300...yesterday's open .4055...that is why I chart with an OHLC bar instead of candlesticks....
you are going to see my same posts to the insane asylum yahoo mb..they need all the help they can get over there....lol
bull
I know...I had one friend running to Scottrade office with a cashiers check so no hold ....just to load up on more shs....I am not worried about the short clowns....
bull
All About Perspective: Friday...due for a pullback....down .08 ....not a bad day....last red day in a sea of green we opened @ .3929 and closed @ .3270...perspective guys....down .0659
bull
Shorts had their day today...they haven't lately...why do u think someone went to the trouble to pay someone to write on pos SA..they were desperate and panicked for their clients..it isn't the author..he got paid to write and then he shorted the stock to take advantage..who wouldn't.. and then they plotted when to release it...as we go up it will happen again...they covered the short and they will live to short another day...fundamentals win over in the long run when you have a good stock.
bull
Don't be caught without your core position going into the weekend....
dbmich....this will happen again as we go up....it shook out some weak hands but mostly it was traders...I wouldn't read anything into anything today....dropped on a short hit...
bull
Nuvilex Inc (NVLX) news: Nuvilex: Paid Promotion ......Disclosure: I am short NVLX...enough said....I didn't read any further than that....lol
bull
Salvatorey1234 I thought u said u were going away...look we all see through you...and if we believed any of it....this small little itty bitty stock would of crashed big time already...this stock has strength and all of the longs went nowhere today...chart the stock..my charts are saying this stock held up under a scam hit piece really well....so go away and pick your re-entry and leave the newbies alone...
bull
I know the newbies want to think this is so terrible...it is not...why ..because the selling you saw is not from any longs that are holding...it is from all the momo's ( momentum traders ) who jumped on a moving stock from alerts and took the wild ride...they all jumped off today....so even though you don't see this as a good thing...it is...it gets rid of some froth...some of those will just go away but most of them will be loading up again...you just hold for the long run...trust some longs that have been here before and don't listen to the garbage of the some of the traders either ...they are as bad as the shorts...as soon as they sell they will trash the company...it is textbook here...
bull
J Ehrat...did you read the same article....Disclosure: I am short NVLX.
Glass Half Full
this short just gave you the buying op you wish you would of done when it bounced within minutes and headed to over .60....don't be stupid here...
it will be bought back up....too many buyers know what they have here and are not dumb enough to even bother with some short who writes a hit article....
watch
bull
how many of you newbies know why you own this stock instead of just buying this stock...do some DD and you might become a long term holder
bull
I was wondering how long it would take for some short seller to put it out...wait a day or 2 and you will have a rebuttal ...
bull
and Mica and nite are getting their A handed to them....lol
bull
you will have short covering on every pullback....you will have major adding to positions....you will have the ones with sellers remorse wanting back in....you will have the ones who wished they had bought more....how do I know this .....read all the posts on all the mb's...this will not stay down....I said only one day pullback last time by reading the chart and watching the trading....
and the momentum this stock has could bring us into the .50's again today....
keep this in mind when you dump your shs...
I am not selling one sh.
bull
lilypad....I can't help but laugh....sorry ...if the 52 week high worries you ...how about the fact that it is a 7 ( seven ) year high......I am long and holding every shs I have....do some DD
good luck
bull
Tangents ...you do that ...and in the mean time SPARE US...we know what you are doing...you don't act like a paid short basher so you sold and now you are belittling yourself with this crap to make the stock look bad thinking that your 1 little person posts are going to make ANYONE sell...seen it before many times ...annoying every time..so chill out watch the stock and look for a re-entry because we all know that is what you want to do...YOU SOLD...AND SAW THE STRENGTH IN THE STOCK...and now this is just another method of whining about why you sold and you back in...give us a break...
bull
Tangents...I already know about the MASSIVE campaigns ...do you get what I'm saying...as a long that intends to hold for quite a while ...I DON'T CARE about the penny pushing crap....makes no difference to me...I know it's out there ...I can read...I don't care..and I bet any real longs on this stock or others don't care either...I don't usually buy stocks at this price...I bought for the technology and the fact the timing was perfect for me to buy in....granted I don't own what some people own..but I guarantee my 364,000 shs are going to pay off for us wonderfully...and I know bio's....I own them for quite a while....let's give it a rest and in even a few weeks come back ...and we will talk again...and then in a few months and then in a few years...
bull